Trinity Biotech plc
TRIB
$0.7529
$0.04496.34%
NASDAQ
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -24.02M | -28.60M | -30.82M | -32.20M |
| Total Depreciation and Amortization | -- | 1.78M | 1.94M | 2.46M | 1.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 14.31M | 19.52M | 24.09M | 37.14M |
| Change in Net Operating Assets | -- | -3.63M | -3.32M | -838.00K | -5.99M |
| Cash from Operations | -- | -11.55M | -9.97M | -4.63M | 1.58M |
| Capital Expenditure | -- | -803.00K | -1.03M | -1.22M | -1.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 28.43M | 28.43M | 28.43M | -- |
| Other Investing Activities | -- | -2.87M | -2.89M | -3.13M | -6.12M |
| Cash from Investing | -- | 24.76M | 24.51M | 24.07M | -7.32M |
| Total Debt Issued | -- | 5.00M | 5.00M | 5.00M | 100.02M |
| Total Debt Repaid | -- | -12.37M | -12.41M | -12.53M | -124.15M |
| Issuance of Common Stock | -- | -- | 380.00K | 380.00K | 25.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -8.68M | -8.65M | -8.48M | -15.38M |
| Cash from Financing | -- | -16.05M | -15.68M | -15.62M | -14.50M |
| Foreign Exchange rate Adjustments | -- | -44.00K | 147.00K | -46.00K | 17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -2.89M | -993.00K | 3.78M | -20.22M |